Skip to main content
. Author manuscript; available in PMC: 2014 Feb 1.
Published in final edited form as: Pharmacogenomics J. 2012 Apr 10;13(4):369–377. doi: 10.1038/tpj.2012.10

TABLE 4.

CYP2C8 Genotype Frequencies

CYP2C8 Genotype Observed (expecteda) frequency (%)
African-American (n = 248) Asian (n = 249) Caucasian (n = 248) Hispanic (n = 248) Ashkenazi Jewish (n = 249)
Wild-type
 *1/*1 76.6 (76.9) 92.0 (92.5) 77.2 (75.7) 78.6 (78.3) 80.0 (81.0)
Heterozygous
 *1/*2 18.1 (17.7) 0.8 (0.8) 0.4 (0.3) 4.0 (3.9) 0.8 (0.7)
 *1/*3 2.0 (1.8) 4.4 (4.3) 14.8 (16.4) 12.9 (13.6) 15.2 (13.7)
 *1/*4 2.0 (2.1) 2.4 (2.3) 4.4 (5.6) 2.8 (2.9) 4.0 (3.6)
 *1/*14 0.0 (0.0) 0.0 (0.0) 0.4 (0.3) 0.0 (0.3) 0.0 (0.0)

TOTAL: 22.2 (21.6) 7.6 (7.4) 20.0 (22.6) 19.8 (20.3) 20.0 (18.0)
Homozygous Variant/Compound Heterozygous
 *2/*2 0.8 (1.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0)
 *2/*3 0.0 (0.2) 0.0 (0.0) 0.0 (0.0) 0.4 (0.3) 0.0 (0.1)
 *2/*4 0.4 (0.2) 0.0 (0.0) 0.0 (0.0) 0.0(0.1) 0.0 (0.0)
 *3/*3 0.0 (0.0) 0.0 (0.0) 0.8 (0.9) 0.8 (0.6) 0.0 (0.6)
 *3/*4 0.0 (0.0) 0.0 (0.1) 2.0 (0.6) 0.4 (0.3) 0.0 (0.3)

TOTAL: 0.4 (0.3) 0.0 (0.1) 2.8 (1.5) 1.2 (0.9) 0.0 (0.9)

n: number of subjects.

a

Predicted Hardy-Weinberg frequencies.